Appili Therapeutics Inc. (TSX:APLI)
Canada flag Canada · Delayed Price · Currency is CAD
0.0100
0.00 (0.00%)
Sep 3, 2026, 4:10 PM EST

Appili Therapeutics Financials Overview

Millions CAD. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
0.360.240.10.830.331.39
Revenue Growth
260.48%143.10%-87.86%147.59%-75.97%-
Gross Profit
0.360.240.10.830.331.39
Operating Income
-6.54-6.52-10.09-8.05-7.91-24.68
Net Income
-4.69-4.24-2.62-3.78-9.24-25.12
Earnings Per Share
-0.04-0.03-0.02-0.03-0.08-0.38
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.140.041.230.092.476.66
Total Debt
13.3312.9412.298.187.674.98
Net Cash (Debt)
-13.19-12.9-11.07-8.09-5.21.69
Net Cash Growth
------88.83%
Net Cash Per Share
-0.10-0.10-0.09-0.07-0.050.03

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-1.37-1.340.87-2.46-10.1-19.08
Capital Expenditures
---0-0.03-0-
Free Cash Flow
-1.37-1.340.87-2.49-10.1-19.08
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-1804.94%-2672.16%-10040.58%-972.94%-2368.29%-1774.56%
Pretax Margin
-1272.94%-1693.59%-2594.37%-448.55%-2755.01%-1803.42%
Profit Margin
-1295.49%-1736.73%-2613.12%-456.96%-2765.90%-1806.18%
FCF Margin
-377.83%-547.72%862.63%-301.44%-3022.65%-1372.07%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Forward PE
-3.483.483.483.483.48
P/FCF Ratio
--4.90---
PS Ratio
3.668.1342.265.1314.526.15